Test Price
2,800 AED✅ Home Collection Available
LAMA1 Gene Poretti-Boltshauser Syndrome Genetic Test in UAE | 2800 AED | 2026 DHA Guidelines
تحليل طفرة جين LAMA1 لمتلازمة بورتيه-بولتسهاوزر في الإمارات | 2800 درهم | معتمد من هيئة الصحة بدبي
الملخص التنفيذي | Executive Summary
يُعد تحليل جين LAMA1 بتقنية التسلسل الجيني الشامل (NGS) الاختبار الأكثر دقة لتأكيد متلازمة بورتيه-بولتسهاوزر. نضمن دقة تشخيصية تصل إلى 99.9% عبر مختبرات حاصلة على شهادة ISO. نقدم خدمة سحب العينات المنزلية الآمنة والمعتمدة، مع استشارة وراثية هاتفية بعد النتيجة، وفحص مباشر لأهلية التأمين عبر الواتساب.
- ✓ ضمان الدقة | Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO 9001:2015 Accredited Processing – NGS covers all coding exons and splice junctions.
- ✓ خدمات لوجستية متميزة | Premium Logistics: Paid Hospital-Grade Home Collection via ISO-Certified Cold-Chain logistics, VIP Mobile Phlebotomy, and FTA card option for remote areas.
- ✓ الدعم السريري | Clinical Guidance: Telephonic Post-Test Clinical Guidance by a DHA-licensed genetic counselor to interpret variant pathogenicity and discuss next steps.
- ✓ التأمين | Insurance: Direct Billing Verification via WhatsApp +971 54 548 8731 – instant eligibility check for all major UAE providers.
Overview of LAMA1 Gene Poretti-Boltshauser Syndrome Testing
The LAMA1 NGS test detects pathogenic variants in the LAMA1 gene responsible for Poretti-Boltshauser syndrome, a congenital cerebellar dysplasia with retinal dystrophy. يكشف هذا الاختبار عن الطفرات المسببة للمتلازمة بدقة فائقة، مما يتيح التشخيص المبكر والتخطيط الأسري. Our test uses Next-Generation Sequencing to analyze all coding regions, providing a definitive molecular diagnosis in 3–4 weeks.
| Parameter | Our Test (DNA Labs UAE) | Closest Alternative (Sanger Sequencing) |
|---|---|---|
| Precision | >99.9% analytical sensitivity/specificity for SNVs and small indels | High for targeted exons, may miss deep intronic variants |
| Method | NGS with full gene coverage, CNV detection | Sanger sequencing of individual exons, no CNV |
| Turnaround Time | 3–4 Weeks | 6–8 Weeks (if performed exon-by-exon) |
| Sample Collection | Home blood draw, FTA card, or extracted DNA | Hospital/lab visit often required |
Physician Insight & Safety Protocol
“As a clinical geneticist, I understand the emotional weight of a potential syndromic diagnosis. A positive LAMA1 result can be overwhelming, but it is the first crucial step toward tailored early intervention, surveillance for retinal and neurological complications, and informed family planning. Always interpret this result within the full clinical and radiological context.”
— Dr. PRABHAKAR REDDY, DHA License No. 61713011
Medication Warning & Safety Notice
Do not discontinue prescribed medication without consulting your doctor. This test is not a substitute for acute clinical assessment.
Exclusion Criteria & Emergency Red Flags
- Sample Rejection: Blood collected in wrong tube type, sample received at ambient temperature >48 hours, or insufficient volume. FTA cards must be fully dried before shipping.
- Patient Condition: Recent (within 2 weeks) blood transfusion or bone marrow transplant may invalidate germline DNA analysis.
- ER Red Flags: If the patient develops acute neurological decline, seizures, or signs of increased intracranial pressure, seek emergency care immediately—do not wait for genetic test results.
- Genetic Counselling is Mandatory: Pre-test consent requires documentation of a three-generation pedigree; results must be disclosed in a professional genetic counselling setting per UAE CDS Law 2026 for minors.
Patient FAQ & Clinical Guidance
1. How accurate is the LAMA1 NGS test for diagnosing Poretti-Boltshauser syndrome?
Our NGS panel achieves 99.9% diagnostic sensitivity for single nucleotide variants and small insertions/deletions across the entire LAMA1 coding region, outperforming older single-exon methods. This comprehensive analysis reduces the need for multiple follow-up tests and delivers a definitive molecular diagnosis with a 3-4 week turnaround.
2. What preparation is required before the blood draw?
No fasting or medication adjustments are normally needed. However, you must provide a complete clinical history and inform the collection team of any recent blood transfusions or immunosuppressive therapy, as these can interfere with DNA quality. A pre-test genetic counselling session is mandatory to draw the family pedigree.
3. هل يمكن إجراء الاختبار للأطفال الرضع؟ وما هي الإجراءات القانونية المطلوبة؟
يُسمح بإجراء الاختبار للقُصَّر بموجب قانون الخدمات السريرية التشخيصية لعام 2026 في دولة الإمارات، بشرط تقديم موافقة خطية من الوالدين أو الوصي القانوني بعد جلسة استشارة وراثية كاملة. يتم سحب العينة من كعب القدم للأطفال حديثي الولادة، وتُلغى الحاجة إلى حقن متكررة، مع ضمان الخصوصية التامة بموجب قانون حماية البيانات الشخصية الإماراتي.
UAE Compliance & Data Privacy
This is provided under DHA Facility License #9834453 and adheres to Federal Decree-Law No. 41 of 2024 (Art. 87) on patient consent and advertising, UAE Clinical Diagnostic Services Law 2026 for minors, and UAE Personal Data Protection Law (PDPL). All genetic data is stored on encrypted servers within the UAE with no cross-border transfer without explicit consent. ISO 9001:2015 Certification: INT/EGQ/2509DA/3139.
For immediate assistance or to schedule a home collection, contact +971545488731 (WhatsApp/Phone) | 8 AM – 11 PM daily.
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians